Biacore launches new generation system
Biacore International, a global supplier of systems for protein interaction analysis, has launched a new generation system for protein interaction analysis.
Biacore International, a global supplier of systems for protein interaction analysis, has launched a new generation system for protein interaction analysis.
Providing comprehensive information about how proteins interact with other molecules, the Biacore T100 is suitable for many applications, such as elucidation of disease pathways, definition of therapeutic targets, selection of drug candidates and decisions on the safety of a protein therapeutic.
Using the new system, scientists can determine affinity and rate constants, binding specificity, concentration and thermodynamic parameters. In this way, time-consuming applications such as antibody characterisation, which could take weeks by conventional methods, can be completed in days.
To fulfil stringent regulatory requirements, Biacore T100 has been designed with a high level of in-built GLP/GMP/GCP support and 21 CFR Part 11 compliance. An optional GxP support package will save users significant time during validation.
'Biacore T100 is our new flagship system, the fruit of our skills and expertise gained through 15 years of experience since we introduced real time protein interaction analysis into the life science market,' said Erik Wallden, Biacore president and ceo.